These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 7194057

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of etofylline clofibrate on experimental thrombus formation and prostacyclin activation.
    Metz G, Sim AK, McCraw AP, Cleland ME.
    Arzneimittelforschung; 1986 Sep; 36(9):1363-5. PubMed ID: 3539125
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
    Ginocchio AV, Metz G.
    Arzneimittelforschung; 1980 Sep; 30(11b):2032-4. PubMed ID: 7194054
    [Abstract] [Full Text] [Related]

  • 6. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
    Ditschuneit HH, Hutt V, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1980 Sep; 30(11b):2063-7. PubMed ID: 7194061
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J, Mühlfellner G, Mühlfellner O, Hausmann L, Schubotz R.
    Arzneimittelforschung; 1980 Sep; 30(11b):2059-62. PubMed ID: 7194060
    [Abstract] [Full Text] [Related]

  • 9. [On the uricosuric activity of etofylline clofibrate (author's transl)].
    Ziegler WJ.
    Arzneimittelforschung; 1980 Sep; 30(11b):2073-4. PubMed ID: 7194063
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacology and toxicology of etofylline clofibrate].
    Sterner W, Korn WD.
    Arzneimittelforschung; 1980 Sep; 30(11b):2023-31. PubMed ID: 7194053
    [Abstract] [Full Text] [Related]

  • 11. Biopharmaceutic evaluation of etofylline clofibrate and its drug formulation.
    Ritschel WA, Thompson GA, Lücker PW, Wetzelsberger K.
    Arzneimittelforschung; 1980 Sep; 30(11b):2020-3. PubMed ID: 7194052
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
    Vorberg G, Ziegler WJ.
    Arzneimittelforschung; 1980 Sep; 30(11b):2068-72. PubMed ID: 7194062
    [Abstract] [Full Text] [Related]

  • 13. [Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author's transl)].
    Metz G, Specker M.
    Arzneimittelforschung; 1980 Sep; 30(11b):2014-9. PubMed ID: 7194051
    [Abstract] [Full Text] [Related]

  • 14. [Clinical effects and tolerance of etofylline clofibrate].
    Ziegler WJ, Metz G, Specker M.
    Arzneimittelforschung; 1980 Sep; 30(11b):2053-8. PubMed ID: 7194059
    [Abstract] [Full Text] [Related]

  • 15. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y, Sugidachi A, Ogawa T, Jakubowski JA, Hashimoto M, Isobe T, Otsuguro K, Asai F.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):276-82. PubMed ID: 17996866
    [Abstract] [Full Text] [Related]

  • 16. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE, Bergqvist D, Tangen O.
    Acta Chir Scand; 1975 Jan 28; 141(1):40-2. PubMed ID: 1092111
    [Abstract] [Full Text] [Related]

  • 17. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
    Bruseghini L, Vilageliu J, Freixes J.
    Arzneimittelforschung; 1981 Jan 28; 31(10a):1790-5. PubMed ID: 6797443
    [Abstract] [Full Text] [Related]

  • 18. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T, Hashizume H, Ogawa T, Okayama T, Nukui E, Oshima K, Morikawa T, Hagiwara M.
    Arzneimittelforschung; 1997 Jan 28; 47(1):13-8. PubMed ID: 9037437
    [Abstract] [Full Text] [Related]

  • 19. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
    Cadroy Y, Thalamas C, Sakariassen K, Boneu B.
    Thromb Res; 2005 Jan 28; 116(4):293-300. PubMed ID: 16038713
    [Abstract] [Full Text] [Related]

  • 20. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats].
    Xu HL, Feng YP.
    Yao Xue Xue Bao; 2001 May 28; 36(5):329-33. PubMed ID: 12584852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.